The colchicine derivative CT20126 shows a novel microtubule-modulating activity with apoptosis.
- Author:
Sung Kuk KIM
1
;
Sang Min CHO
;
Ho KIM
;
Heon SEOK
;
Soon Ok KIM
;
Taeg Kyu KWON
;
Jong Soo CHANG
Author Information
1. Department of Life Science, College of Natural Science, Daejin University, Kyeonggido, Korea. jchang@daejin.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
apoptosis;
cell cycle arrest;
colchicine analog;
CT20126;
microtubule disruption;
tubulin acetylation
- MeSH:
Acetylation/drug effects;
Animals;
Apoptosis/*drug effects;
COS Cells;
Caspase 3/metabolism;
Cattle;
Cell Division/drug effects;
Cercopithecus aethiops;
Colchicine/*analogs & derivatives/chemistry/pharmacology;
Enzyme Activation/drug effects;
G2 Phase/drug effects;
Humans;
Jurkat Cells;
Microtubules/*metabolism;
Poly(ADP-ribose) Polymerases/metabolism;
Tubulin/metabolism;
Tubulin Modulators/chemistry/*pharmacology
- From:Experimental & Molecular Medicine
2013;45(4):e19-
- CountryRepublic of Korea
- Language:English
-
Abstract:
New colchicine analogs have been synthesized with the aim of developing stronger potential anticancer activities. Among the analogs, CT20126 has been previously reported to show immunosuppressive activities. Here, we report that CT20126 also shows potential anticancer effects via an unusual mechanism: the modulation of microtubule integrity and cell cycle arrest at the G2/M phase before apoptosis. When we treated COS-7 cells with CT20126 (5 muM), the normal thread-like microtubules were disrupted into tubulin dimers within 10 min and thereafter repolymerized into short, thick filaments. In contrast, cells treated with the same concentration of colchicine exhibited microtubule depolymerization after 20 min and never underwent repolymerization. Furthermore, optical density (OD) analysis (350 nm) with purified tubulin showed that CT20126 had a higher repolymerizing activity than that of Taxol, a potent microtubule-polymerizing agent. These results suggest that the effects of CT20126 on microtubule integrity differ from those of colchicine: the analog first destabilizes microtubules and then stabilizes the disrupted tubulins into short, thick polymers. Furthermore, CT20126 induced a greater level of apoptotic activity in Jurkat T cells than colchicine (assessed by G2/M arrest, caspase-3 activation and cell sorting). At 20 nM, CT20126 induced 47% apoptosis among Jurkat T cells, whereas colchicine induced only 33% apoptosis. Our results suggest that the colchicine analog CT20126 can potently induce apoptosis by disrupting microtubule integrity in a manner that differs from that of colchicine or Taxol.
